CBIO

Crescent Biopharma, Inc. Common Stock

54 hedge funds and large institutions have $46.6M invested in Crescent Biopharma, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 13 closing their positions.

Holders
54
Holders Change
+6
Holders Change %
+12.5%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
14
Reduced
10
Closed
13
Calls
$721K
Puts
$607K
Net Calls
+$114K
Net Calls Change
-$924K